Philips unveils tiniest TEE probe
Other headlines:eRAD boosts interoperability of PACS
Philips unveils tiniest TEE probe
Philips claimed the world's smallest transesophageal echocardiography (TEE) transducer this week at the American Society of Echocardiography. Its newly unveiled microTEE, which is about one-third the size of pediatric TEE transducers now on the market, was developed specifically for cardiac imaging of neonatal patients too small for other such probes. The microTEE will be available for sale globally this summer as part of the company's latest Vision release for the Philips iE33 intelligent echocardiography system. Although particularly suited to small neonates, the microTee may also help adult patients who have trouble tolerating standard-size TEE probes.
eRAD boosts interoperability of PACS
PACS/IT vendor eRAD has upgraded its eRAD RIS/PACS v6 with a new web-based platform designed to integrate images, reports, and other data from information systems built by other vendors. The new uniRAD can be customized to fit specific preferences at the site, while offering the flexibility to accommodate a range of external systems. Initial installations of the new platform are in place in the U.S. and Hungary.
Philips Launches Flash 5100 Point-of-Care Ultrasound System
June 17th 2025Offering a combination of intuitive touchscreen controls and enhanced image clarity, the portable Flash 5100 POC ultrasound platform reportedly facilitates confident and rapid assessment in emergency radiology and critical care settings.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
